Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lannett Hits A High After Loss Of Levothyroxine
Company Plans To Launch Several New Products By End Of June
May 12 2020
•
By
Akriti Seth
Lannett’s pipeline has 20 products in development and 17 pending ANDAs • Source: Shutterstock
More from Strategy
More from Business